Legal / IP

AstraZenecaBoehringer Ingelheim

Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA

The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First…

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Biocytogen PharmaceuticalsHKG: 2315

Biocytogen Prevails in Shanghai IP Court as Harbour BioMed Patent Infringement Claims Dismissed – RenNano Platform Cleared of Antibody Technology Violations

Harbour BioMedHKG: 2142

Harbour BioMed Wins $20.2 Million Patent Verdict Against Amgen in Delaware Court

NHC (NHFPC)NHSA (prev. SMIA)

China’s Seven Ministries Issue Revised Pharmaceutical Representative Management Measures to Combat Commercial Bribery and Strengthen Industry Oversight

AbbottDiabetes

UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare’s iCanCGM App in 17 European Countries Following Abbott Patent Claim

Show More